155 related articles for article (PubMed ID: 2496522)
1. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
[TBL] [Abstract][Full Text] [Related]
2. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
3. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract][Full Text] [Related]
4. Osteonectin--a differentiation marker of bone cells.
Jundt G; Berghäuser KH; Termine JD; Schulz A
Cell Tissue Res; 1987 May; 248(2):409-15. PubMed ID: 3581152
[TBL] [Abstract][Full Text] [Related]
5. Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
Bosse A; Ueda Y; Wuisman P; Jones DB; Vollmer E; Roessner A
J Cancer Res Clin Oncol; 1991; 117(1):43-9. PubMed ID: 1997469
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of osteonectin in various types of osteosarcoma.
Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological demonstration of osteonectin in normal bone tissue and in bone tumors.
Schulz A; Jundt G
Curr Top Pathol; 1989; 80():31-54. PubMed ID: 2776495
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
[TBL] [Abstract][Full Text] [Related]
9. YJ5 as an immunohistochemical marker of osteogenic lineage.
Chua K; Virshup DM; Odono EG; Chang KTE; Tan NJH; Hue SS; Sim AYL; Lee VKM
Pathology; 2021 Feb; 53(2):229-238. PubMed ID: 33187685
[TBL] [Abstract][Full Text] [Related]
10. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
11. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
12. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
[TBL] [Abstract][Full Text] [Related]
13. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin expression in bone tumours and tumour-like lesions.
Inagaki Y; Hookway ES; Kashima TG; Munemoto M; Tanaka Y; Hassan AB; Oppermann U; Athanasou NA
Histopathology; 2016 Sep; 69(3):470-8. PubMed ID: 26896083
[TBL] [Abstract][Full Text] [Related]
16. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
Fanburg JC; Rosenberg AE; Weaver DL; Leslie KO; Mann KG; Taatjes DJ; Tracy RP
Am J Clin Pathol; 1997 Oct; 108(4):464-73. PubMed ID: 9322601
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin expression in skeletal sarcomas.
Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
[TBL] [Abstract][Full Text] [Related]
18. Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumours.
Kashima TG; Dongre A; Oppermann U; Athanasou NA
Virchows Arch; 2013 May; 462(5):583-91. PubMed ID: 23559304
[TBL] [Abstract][Full Text] [Related]
19. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
Park YK; Yang MH; Park HR
Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
[TBL] [Abstract][Full Text] [Related]
20. [Bone matrix production in osteosarcoma].
Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
